# Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients

> **NCT03226691** · PHASE1 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 15 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Plerixafor

## Key facts

- **NCT ID:** NCT03226691
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-25
- **Primary completion:** 2019-02-27
- **Final completion:** 2019-02-27
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03226691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03226691, "Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03226691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*